Bay City Capital Llc

Insider Reports History

Location
750 Battery Street Ste 400, San Francisco, CA
Signature
Bay City Capital LLC, a Delaware limited liability company, By: /s/ Fred Craves, Managing Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bay City Capital Llc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1.13M $937K $0.83 Oct 26, 2021 Indirect
MADRIGAL PHARMACEUTICALS, INC. 10%+ Owner Common Stock 1.26K $308K $243.92 Dec 3, 2021 Direct
MADRIGAL PHARMACEUTICALS, INC. 10%+ Owner Common Stock 0 $243.92 Dec 3, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Oct 26, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 Oct 26, 2021 Indirect

Insider Reports Filed by Bay City Capital Llc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MDGL MADRIGAL PHARMACEUTICALS, INC. Dec 3, 2021 3 $0 4 Dec 7, 2021 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 26, 2021 5 $5M 4 Oct 26, 2021 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 10%+ Owner